These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36803109)

  • 21. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
    Flynn MC; Kraakman MJ; Tikellis C; Lee MKS; Hanssen NMJ; Kammoun HL; Pickering RJ; Dragoljevic D; Al-Sharea A; Barrett TJ; Hortle F; Byrne FL; Olzomer E; McCarthy DA; Schalkwijk CG; Forbes JM; Hoehn K; Makowski L; Lancaster GI; El-Osta A; Fisher EA; Goldberg IJ; Cooper ME; Nagareddy PR; Thomas MC; Murphy AJ
    Circ Res; 2020 Sep; 127(7):877-892. PubMed ID: 32564710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice.
    Terasaki M; Nagashima M; Nohtomi K; Kohashi K; Tomoyasu M; Sinmura K; Nogi Y; Katayama Y; Sato K; Itoh F; Watanabe T; Hirano T
    PLoS One; 2013; 8(8):e70933. PubMed ID: 23967137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression.
    Wang Z; Guo X; Zhang Q; Du G; Zeng Z; Zheng C; Wei Y
    Int J Med Sci; 2021; 18(16):3652-3664. PubMed ID: 34790037
    [No Abstract]   [Full Text] [Related]  

  • 24. Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role.
    Fu J; Xu H; Wu F; Tu Q; Dong X; Xie H; Cao Z
    Int J Cardiol; 2022 Nov; 367():56-62. PubMed ID: 35931206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
    Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
    Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZBTB20 Positively Regulates Oxidative Stress, Mitochondrial Fission, and Inflammatory Responses of ox-LDL-Induced Macrophages in Atherosclerosis.
    Tao J; Qiu J; Lu L; Zhang L; Fu Y; Wang M; Han J; Shi M; Li L; Zhao Z; Wei F; Wang C; Zhang H; Liang S; Zheng J
    Oxid Med Cell Longev; 2021; 2021():5590855. PubMed ID: 33777314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of IGF2BP1 restrains ox-LDL-induced lipid accumulation and inflammation by reducing RUNX1 expression and promoting autophagy in macrophages.
    Liu M; Tao G; Cao Y; Hu Y; Zhang Z
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e22994. PubMed ID: 35179253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
    Li H; Song D; Liu Q; Li L; Sun X; Guo J; Li D; Li P
    Mol Med; 2022 Sep; 28(1):120. PubMed ID: 36180828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grb2 is required for atherosclerotic lesion formation.
    Proctor BM; Ren J; Chen Z; Schneider JG; Coleman T; Lupu TS; Semenkovich CF; Muslin AJ
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1361-7. PubMed ID: 17363695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin alleviates atherosclerosis by suppressing oxidized LDL-induced senescence in plaque macrophage via inhibiting the p38MAPK/p16 pathway.
    Luo G; Xiang L; Xiao L
    J Nutr Biochem; 2023 Jun; 116():109314. PubMed ID: 36924853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CISD1 protects against atherosclerosis by suppressing lipid accumulation and inflammation via mediating Drp1.
    Hua J; Gao Z; Zhong S; Wei B; Zhu J; Ying R
    Biochem Biophys Res Commun; 2021 Nov; 577():80-88. PubMed ID: 34509082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
    Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
    Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes.
    Fukuhara-Takaki K; Sakai M; Sakamoto Y; Takeya M; Horiuchi S
    J Biol Chem; 2005 Feb; 280(5):3355-64. PubMed ID: 15556945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis.
    Di Bartolo BA; Cartland SP; Genner S; Manuneedhi Cholan P; Vellozzi M; Rye KA; Kavurma MM
    J Diabetes Res; 2021; 2021():6668506. PubMed ID: 34095317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose.
    Hayek T; Kaplan M; Kerry R; Aviram M
    Atherosclerosis; 2007 Dec; 195(2):277-86. PubMed ID: 17258748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Lewis P; Stefanovic N; Pete J; Calkin AC; Giunti S; Thallas-Bonke V; Jandeleit-Dahm KA; Allen TJ; Kola I; Cooper ME; de Haan JB
    Circulation; 2007 Apr; 115(16):2178-87. PubMed ID: 17420349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.
    Brophy ML; Dong Y; Tao H; Yancey PG; Song K; Zhang K; Wen A; Wu H; Lee Y; Malovichko MV; Sithu SD; Wong S; Yu L; Kocher O; Bischoff J; Srivastava S; Linton MF; Ley K; Chen H
    Circ Res; 2019 Feb; 124(4):e6-e19. PubMed ID: 30595089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.